These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 27736029

  • 21. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
    Datta P, Bang S, Yue Z, Beach T, Stilgenbauer M, Wang H, Bowers DJ, Kurokawa M, Xiao H, Zheng YR.
    Dalton Trans; 2020 Jun 23; 49(24):8107-8113. PubMed ID: 32490446
    [Abstract] [Full Text] [Related]

  • 22. Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer.
    Lu H, Tong W, Jiang M, Liu H, Meng C, Wang K, Mu X.
    ACS Nano; 2024 Aug 13; 18(32):21156-21170. PubMed ID: 39088743
    [Abstract] [Full Text] [Related]

  • 23. DNA Nanostructures as Pt(IV) Prodrug Delivery Systems to Combat Chemoresistance.
    Zhong YF, Cheng J, Liu Y, Luo T, Wang Y, Jiang K, Mo F, Song J.
    Small; 2020 Sep 13; 16(38):e2003646. PubMed ID: 32815274
    [Abstract] [Full Text] [Related]

  • 24. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat.
    To KK, Tong WS, Fu LW.
    Lung Cancer; 2017 Jan 13; 103():58-65. PubMed ID: 28024697
    [Abstract] [Full Text] [Related]

  • 25. A red-light activatable and mitochondrion-targeting PtIV complex to overcome drug resistance.
    Li Y, Wang Z, Qi Y, Tang Z, Li X, Huang Y.
    Chem Commun (Camb); 2022 Jul 26; 58(60):8404-8407. PubMed ID: 35796077
    [Abstract] [Full Text] [Related]

  • 26. Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
    Gibson D.
    J Inorg Biochem; 2021 Apr 26; 217():111353. PubMed ID: 33477089
    [Abstract] [Full Text] [Related]

  • 27. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
    Li Y, Deng Y, Tian X, Ke H, Guo M, Zhu A, Yang T, Guo Z, Ge Z, Yang X, Chen H.
    ACS Nano; 2015 Oct 27; 9(10):9626-37. PubMed ID: 26365698
    [Abstract] [Full Text] [Related]

  • 28. A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells.
    Montagner D, Tolan D, Andriollo E, Gandin V, Marzano C.
    Int J Mol Sci; 2018 Nov 27; 19(12):. PubMed ID: 30486477
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells.
    Yao H, Xu Z, Li C, Tse MK, Tong Z, Zhu G.
    Inorg Chem; 2019 Aug 19; 58(16):11076-11084. PubMed ID: 31393117
    [Abstract] [Full Text] [Related]

  • 30. Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance.
    Hu W, Fang L, Hua W, Gou S.
    J Inorg Biochem; 2017 Oct 19; 175():47-57. PubMed ID: 28700961
    [Abstract] [Full Text] [Related]

  • 31. A Systematic Strategy of Combinational Blow for Overcoming Cascade Drug Resistance via NIR-Light-Triggered Hyperthermia.
    Wang L, Yu Y, Wei D, Zhang L, Zhang X, Zhang G, Ding D, Xiao H, Zhang D.
    Adv Mater; 2021 May 19; 33(20):e2100599. PubMed ID: 33834553
    [Abstract] [Full Text] [Related]

  • 32. Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells.
    Elias MG, Aputen AD, Fatima S, Mann TJ, Karan S, Mikhael M, de Souza P, Gordon CP, Scott KF, Aldrich-Wright JR.
    Int J Mol Sci; 2024 Jul 28; 25(15):. PubMed ID: 39125821
    [Abstract] [Full Text] [Related]

  • 33. NIR Light and GSH Dual-Responsive Upconversion Nanoparticles Loaded with Multifunctional Platinum(IV) Prodrug and RGD Peptide for Precise Cancer Therapy.
    Liu XM, Zhu ZZ, He XR, Zou YH, Chen Q, Wang XY, Liu HM, Qiao X, Wang X, Xu JY.
    ACS Appl Mater Interfaces; 2024 Aug 07; 16(31):40753-40766. PubMed ID: 39046129
    [Abstract] [Full Text] [Related]

  • 34. Construction of Dual Stimuli-Responsive Platinum(IV) Hybrids with NQO1 Targeting Ability and Overcoming Cisplatin Resistance.
    Fang L, Qin X, Zhao J, Gou S.
    Inorg Chem; 2019 Feb 04; 58(3):2191-2200. PubMed ID: 30657321
    [Abstract] [Full Text] [Related]

  • 35. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
    Qiao X, Gao YY, Zheng LX, Ding XJ, Xu LW, Hu JJ, Gao WZ, Xu JY.
    Eur J Med Chem; 2021 Nov 05; 223():113730. PubMed ID: 34388483
    [Abstract] [Full Text] [Related]

  • 36. Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells.
    Wang QE, Milum K, Han C, Huang YW, Wani G, Thomale J, Wani AA.
    Mol Cancer; 2011 Mar 08; 10():24. PubMed ID: 21385444
    [Abstract] [Full Text] [Related]

  • 37. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
    Chen F, Qin X, Xu G, Gou S, Jin X.
    Biochem Pharmacol; 2017 Jul 01; 135():50-68. PubMed ID: 28288821
    [Abstract] [Full Text] [Related]

  • 38. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H, Cheng Q, Yuan S, Ding X, Liu Y.
    Chemistry; 2015 Nov 09; 21(46):16547-54. PubMed ID: 26405808
    [Abstract] [Full Text] [Related]

  • 39. Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
    Bowden NA.
    Cancer Lett; 2014 May 01; 346(2):163-71. PubMed ID: 24462818
    [Abstract] [Full Text] [Related]

  • 40. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
    Huang X, Huang R, Gou S, Wang Z, Liao Z, Wang H.
    Bioorg Med Chem; 2017 Sep 01; 25(17):4686-4700. PubMed ID: 28728896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.